Viewing nowCombretum Tablets 5mg (Bisoprolol Fumarate)
Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Ellison Pharmaceuticals Co., Ltd.

MFDS item code 200402318 · Notified 2004.08.13 · Insurance code 620500060
Treats stable chronic heart failure with reduced left ventricular systolic function, hypertension, and angina
1. Used to treat hypertension and angina, helping to control blood pressure and reduce stress on the heart. 2. In the treatment of stable chronic heart failure with decreased left ventricular contractility, this medication is used in conjunction with ACE inhibitors and diuretics, and may be combined with cardiotonic agents as needed to improve heart function.
Take in the morning on an empty stomach or with breakfast, without chewing, with a beverage. 1. Hypertension, angina pectoris Adults: Administer bisoprolol fumarate 5-10mg orally once daily. 5mg is sufficient for mild cases, while 10mg is administered for severe cases. In special cases, a maximum of 20mg per day may be administered. In patients with severe renal or hepatic impairment, do not exceed 10mg per day. Adjust the dose as appropriate according to age and symptoms. 2. Stable chronic heart failure Adults: Administer bisoprolol fumarate orally once daily, increasing the dose as follows. Treatment with this medicine should be initiated when the patient is in a stable condition without acute symptoms of heart failure. Dose titration The initial dose of this medicine is 1.25mg once daily. Assess tolerability and gradually increase the dose in the following order: 2.5mg, 3.75mg, 5mg, 7.5mg, and 10mg, allowing an interval of at least 2 weeks at each step. The maintenance dose is 10mg once daily. The recommended maximum daily dose is 10mg once daily. During dose titration, closely monitor the patient's condition, including blood pressure and heart rate, and whether symptoms of heart failure worsen. Dose adjustment during treatment If the maximum recommended dose is not well tolerated, consider gradually reducing the dose. If transient worsening of heart failure symptoms, hypotension, or bradycardia occurs, adjustment of the doses of concomitant medicines is recommended. If necessary, temporary dose reduction or interruption of this medicine may be required. Once heart failure symptoms have stabilized, consider restarting this medicine or increasing the dose. Because sudden discontinuation of this medicine may cause acute worsening of heart failure symptoms, gradual dose reduction is recommended. Treatment of stable chronic heart failure with this medicine is generally long-term. Patients with hepatic or renal impairment Pharmacokinetic information is not available for patients with chronic heart failure in these groups; therefore, use particular caution when titrating the dose in these patients. Elderly patients Dose adjustment of this medicine is not necessary.
Pediatric patients: Use of this medicine is not recommended in children because there is no experience with its use in this population.
This medication should be used with caution in patients with certain heart diseases or severely impaired kidney and liver function due to insufficient experience with these cases. Patients with bronchial asthma or chronic obstructive pulmonary disease should take this medication alongside bronchodilators, as asthma symptoms may worsen. This medication may cause allergic reactions, and adrenaline treatment may not always be effective. Patients with psoriasis or a history of psoriasis should consider the risks and benefits of this medication carefully. Patients with certain hormone tumors should use this medication only after administering other drugs. This medication can mask symptoms of hyperthyroidism, so caution is advised for patients with thyroid disorders. Regular health status monitoring is required at the beginning of treatment, and sudden discontinuation can worsen heart conditions, so it should be tapered off gradually under medical supervision. This medication should not be used in patients with diabetic ketoacidosis, severe bradycardia, cardiogenic shock, right heart failure due to pulmonary hypertension, or acute heart failure. It should not be administered to pregnant women or those likely to become pregnant, as it may cause side effects in the fetus and newborn. If breastfeeding, it is advisable to avoid nursing while taking this medication, as it may be excreted in breast milk. Safety in pediatric patients has not been established, so it is not recommended for children. Elderly patients should start with a low dose and be carefully monitored, and dosage adjustment is necessary in cases of impaired kidney or liver function. This medication may affect driving or operating machinery, so caution is advised when starting treatment or changing doses, and alcohol should be avoided during use. In cases of overdose, symptoms such as severe bradycardia, hypotension, bronchospasm, worsening heart failure, and hypoglycemia may occur, requiring immediate medical attention. For long-term use, regular monitoring of heart function, blood pressure, and liver and kidney function is essential, and patients must inform their doctor about other medications they are taking due to potential interactions. Particular caution is needed when combining with calcium channel blockers, central nervous system medications, antiarrhythmics, and antidiabetic agents due to an increased risk of side effects. Before undergoing anesthesia, patients should inform healthcare providers that they are taking this medication and may need to taper it off gradually if necessary. This medication should be stored out of reach of children and kept in its original container to maintain its quality.
Bradycardia, worsening of heart failure, coldness or paralysis of the limbs, hypotension, dizziness, headache, nausea, vomiting, diarrhea, constipation, weakness, fatigue, atrioventricular conduction disorders, orthostatic hypotension, sleep disturbances, depression, bronchospasm, muscle atrophy and spasms, nightmares, hallucinations, decreased tear production, hearing impairment, allergic rhinitis, hypersensitivity reactions, hepatitis, sexual dysfunction, conjunctivitis, exacerbation of psoriasis or psoriasis-like rash, hair loss
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. Additionally, it is best to store it at room temperature between 1°C and 30°C.
A yellowish film-coated tablet shaped like a heart, with a scoreline on one side that is convex on both sides.
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowBisoprolol Fumarate 5mg
Tablet · Prescription medication
Ellison Pharmaceuticals Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Merck Co., Ltd.

Bisoprolol Fumarate 2.5mg
Tablet · Prescription medication
Merck Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Celix Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.